{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:28Z","timestamp":1787020768957,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100009010","name":"Novartis Pharmaceuticals UK Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13063-016-1446-6","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T08:24:58Z","timestamp":1470903898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1606-3175","authenticated-orcid":false,"given":"Elizabeth","family":"Randell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Mark","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleri","family":"Owen-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianna","family":"Angel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheney","family":"Drew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cannings-John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Smalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emer","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Stockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrus J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian R.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,11]]},"reference":[{"issue":"13","key":"1446_CR1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355(13):1345\u201356.","journal-title":"N Engl J Med"},{"issue":"1","key":"1446_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","volume":"52","author":"PJ Vries de","year":"2015","unstructured":"de Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, et al. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist. Pediatr Neurol. 2015;52(1):25\u201335.","journal-title":"Pediatr Neurol"},{"issue":"7","key":"1446_CR3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","volume":"14","author":"P Curatolo","year":"2015","unstructured":"Curatolo P, Moaveroa R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015;14(7):733\u201345.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1446_CR4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1469-8749.1983.tb13771.x","volume":"25","author":"A Hunt","year":"1983","unstructured":"Hunt A. Tuberous sclerosis: a survey of 97 cases. III: Family aspects. Dev Med Child Neurol. 1983;25(3):353\u20137.","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"1446_CR5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molmed.2007.06.003","volume":"13","author":"PJ Vries de","year":"2007","unstructured":"de Vries PJ, Howe CJ. The tuberous sclerosis complex proteins \u2013 a GRIPP on cognition and neurodevelopment. Trends Mol Med. 2007;13(8):319\u201326.","journal-title":"Trends Mol Med"},{"issue":"9","key":"1446_CR6","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3174\/ajnr.A0642","volume":"28","author":"MI Makki","year":"2007","unstructured":"Makki MI, Chugani DC, Janisse J, Chugani HT. Characteristics of abnormal diffusivity in normal-appearing white matter investigated with diffusion tensor MR imaging in tuberous sclerosis complex. AJNR Am J Neuroradiol. 2007;28(9):1662\u20137.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"1446_CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang J, Manning BD. The TSC1\u2013TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 2008;412(2):179\u201390.","journal-title":"Biochem J"},{"issue":"7","key":"1446_CR8","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/onc.2014.17","volume":"34","author":"J Yang","year":"2015","unstructured":"Yang J, Kalogerou M, Samsel PA, Zhang Y, Griffiths DF, Gallacher J, et al. Renal tumours in a Tsc2+\/\u2212 mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin. Oncogene. 2015;34(7):922\u201331.","journal-title":"Oncogene"},{"issue":"8","key":"1446_CR9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","volume":"14","author":"D Ehninger","year":"2008","unstructured":"Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, Kwiatkowski DJ, et al. Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis. Nat Med. 2008;14(8):843\u20138.","journal-title":"Nat Med"},{"issue":"21","key":"1446_CR10","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","volume":"28","author":"L Meikle","year":"2008","unstructured":"Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, Sahin M, et al. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci. 2008;28(21):5422\u201332.","journal-title":"J Neurosci"},{"issue":"19","key":"1446_CR11","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","volume":"363","author":"DA Krueger","year":"2010","unstructured":"Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med. 2010;363(19):1801\u201311.","journal-title":"N Engl J Med"},{"issue":"9861","key":"1446_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","volume":"381","author":"DN Franz","year":"2013","unstructured":"Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2013;381(9861):125\u201332.","journal-title":"Lancet"},{"issue":"2","key":"1446_CR13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJMc072500","volume":"358","author":"DM Davies","year":"2008","unstructured":"Davies DM, Johnson SR, Tattersfield AE, Kingswood JC, Cox JA, McCartney DL, et al. Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. N Engl J Med. 2008;358(2):200\u20133.","journal-title":"N Engl J Med"},{"issue":"12","key":"1446_CR14","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","volume":"17","author":"DM Davies","year":"2011","unstructured":"Davies DM, de Vries PJ, Johnson SR, McCartney DL, Cox JA, Serra AL, et al. Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin Cancer Res. 2011;17(12):4071\u201381.","journal-title":"Clin Cancer Res"},{"issue":"9869","key":"1446_CR15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ Bissler","year":"2013","unstructured":"Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2013;381(9869):817\u201324.","journal-title":"Lancet"},{"issue":"1","key":"1446_CR16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2307\/2530297","volume":"38","author":"TR Fleming","year":"1982","unstructured":"Fleming TR. One-sample multiple testing procedure for phase II clinical trials. Biometrics. 1982;38(1):143\u201351.","journal-title":"Biometrics"},{"key":"1446_CR17","volume-title":"Manual for the Wechsler Abbreviated Scale of Intelligence","author":"D Wechsler","year":"1999","unstructured":"Wechsler D. Manual for the Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: Psychological Corporation; 1999."},{"issue":"1","key":"1446_CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0028-3932(71)90067-4","volume":"9","author":"RC Oldfield","year":"1971","unstructured":"Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971;9(1):97\u2013113.","journal-title":"Neuropsychologia"},{"key":"1446_CR19","volume-title":"The National Adult Reading Test (NART): test manual","author":"HE Nelson","year":"1982","unstructured":"Nelson HE. The National Adult Reading Test (NART): test manual. Windsor, UK: NFER-Nelson; 1982."},{"key":"1446_CR20","volume-title":"BIRT Memory and Information Processing Battery (BMIPB)","author":"AK Coughlan","year":"2007","unstructured":"Coughlan AK, Oddy MJ, Crawford JR. BIRT Memory and Information Processing Battery (BMIPB). London: Brain Injury Rehabilitation Trust; 2007."},{"key":"1446_CR21","unstructured":"Cambridge Neuropsychological Test Automated Battery (CANTAB). Cambridge, UK: Cambridge Cognition; 2008."},{"key":"1446_CR22","volume-title":"Test of Everyday Attention (TEA)","author":"IH Robertson","year":"1994","unstructured":"Robertson IH, Ward T, Ridgeway V, Nimmo-Smith I. Test of Everyday Attention (TEA). San Antonio, TX: Psychological Corporation; 1994."},{"key":"1446_CR23","volume-title":"Multilingual Aphasia Examination","author":"AL Benton","year":"1983","unstructured":"Benton AL, de Hamsher SK, Sivan AB. Multilingual Aphasia Examination. 2nd ed. Iowa City, IA: AJA Associates; 1983.","edition":"2"},{"key":"1446_CR24","volume-title":"Symptom Checklist-90-Revised","author":"LR Derogatis","year":"1975","unstructured":"Derogatis LR. Symptom Checklist-90-Revised. San Antonio, TX: Psychological Corporation; 1975."},{"key":"1446_CR25","volume-title":"Quality of Life in Epilepsy Inventory (QOLIE)","author":"BG Vickrey","year":"1993","unstructured":"Vickrey BG. Quality of Life in Epilepsy Inventory (QOLIE). Santa Monica, CA: RAND Health; 1993."},{"issue":"3","key":"1446_CR26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1059-1311(98)80036-8","volume":"7","author":"GA Baker","year":"1998","unstructured":"Baker GA, Smith DF, Jacoby A, Hayes JA, Chadwick DW. Liverpool Seizure Severity Scale revisited. Seizure. 1998;7(3):201\u20135.","journal-title":"Seizure"},{"key":"1446_CR27","volume-title":"Vineland Adaptive Behavior Scales (Vineland II)","author":"SS Sparrow","year":"2005","unstructured":"Sparrow SS, Cicchetti DV, Balla DA. Vineland Adaptive Behavior Scales (Vineland II). 2nd ed. San Antonio, TX: Psychological Corporation; 2005.","edition":"2"},{"key":"1446_CR28","volume-title":"Social Responsiveness Scale \u2013 Adult version (SRS-A)","author":"JN Constantino","year":"2005","unstructured":"Constantino JN. Social Responsiveness Scale \u2013 Adult version (SRS-A). Los Angeles: Western Psychological Services; 2005."},{"key":"1446_CR29","volume-title":"Social Communication Questionnaire (SCQ)","author":"M Rutter","year":"2003","unstructured":"Rutter M, Bailey A, Lord C. Social Communication Questionnaire (SCQ). Los Angeles: Western Psychological Services; 2003."},{"issue":"2","key":"1446_CR30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.2008.08677.x","volume":"159","author":"GF Hofbauer","year":"2008","unstructured":"Hofbauer GF, Marcollo-Pini A, Corsenca A, Kistler AD, French LE, W\u00fcthrich RP, et al. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis. Br J Dermatol. 2008;159(2):473\u20135.","journal-title":"Br J Dermatol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1446-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:30:03Z","timestamp":1498321803000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-016-1446-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,11]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1446"],"URL":"https:\/\/doi.org\/10.1186\/s13063-016-1446-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,11]]},"article-number":"398"}}